Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity

被引:314
作者
Gisselsson, D [1 ]
Pettersson, L
Höglund, M
Heidenblad, M
Gorunova, L
Wiegant, J
Mertens, F
Dal Cin, P
Mitelman, F
Mandahl, N
机构
[1] Univ Lund Hosp, Dept Clin Genet, SE-22185 Lund, Sweden
[2] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Lab Cytochem & Cytometry, NL-2333 AL Leiden, Netherlands
[3] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium
[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.090013497
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It has long been known that rearrangements of chromosomes through breakage-fusion-bridge (BFB) cycles may cause variability of phenotypic and genetic traits within a cell population. Because intercellular heterogeneity is often found in neoplastic tissues, we investigated the occurrence of BFB events in human solid tumors. Evidence of frequent BFB events was found in malignancies that showed unspecific chromosome aberrations, including ring chromosomes, dicentric chromosomes, and telomeric associations, as well as extensive intratumor heterogeneity in the pattern of structural changes but not in tumors with tumor-specific: aberrations and low variability. Fluorescence in situ hybridization analysis demonstrated that chromosomes participating in anaphase bridge formation were involved in a significantly higher number of structural aberrations than other chromosomes. Tumors with BFB events showed a decreased elimination rate of unstable chromosome aberrations after irradiation compared with normal cells and other tumor cells. This result suggests that a combination of mitotically unstable chromosomes and an elevated tolerance to chromosomal damage leads to constant genomic reorganization in many malignancies, thereby providing a flexible genetic system for clonal evolution and progression.
引用
收藏
页码:5357 / 5362
页数:6
相关论文
共 43 条
  • [31] SUPERNUMERARY RING CHROMOSOMES IN 5 BONE AND SOFT-TISSUE TUMORS OF LOW OR BORDERLINE MALIGNANCY
    ORNDAL, C
    MANDAHL, N
    RYDHOLM, A
    WILLEN, H
    BROSJO, O
    HEIM, S
    MITELMAN, F
    [J]. CANCER GENETICS AND CYTOGENETICS, 1992, 60 (02) : 170 - 175
  • [32] CYTOGENETIC INTRATUMOR HETEROGENEITY IN SOFT-TISSUE TUMORS
    ORNDAL, C
    RYDHOLM, A
    WILLEN, H
    MITELMAN, F
    MANDAHL, N
    [J]. CANCER GENETICS AND CYTOGENETICS, 1994, 78 (02) : 127 - 137
  • [33] PANAGOPOULOS I, 1994, CANCER RES, V54, P6500
  • [34] CHROMOSOME-12 ORIGIN IN RINGS AND GIANT MARKERS IN WELL-DIFFERENTIATED LIPOSARCOMA
    PEDEUTOUR, F
    SUIJKERBUIJK, RF
    VANGAAL, J
    VANDEKLUNDERT, W
    COINDRE, JM
    VANHAELST, A
    COLLIN, F
    HUFFERMANN, K
    TURCCAREL, C
    [J]. CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) : 133 - 134
  • [35] CHROMOSOME-ABERRATIONS IN 35 PRIMARY OVARIAN CARCINOMAS
    PEJOVIC, T
    HEIM, S
    MANDAHL, N
    BALDETORP, B
    ELMFORS, B
    FLODERUS, UM
    FURGYIK, S
    HELM, G
    HIMMELMANN, A
    WILLEN, H
    MITELMAN, F
    [J]. GENES CHROMOSOMES & CANCER, 1992, 4 (01) : 58 - 68
  • [36] Reynolds TY, 1996, CANCER RES, V56, P5754
  • [37] CYTOGENETIC STUDY OF SOLID OVARIAN-TUMORS
    ROBERTS, CG
    TATTERSALL, MHN
    [J]. CANCER GENETICS AND CYTOGENETICS, 1990, 48 (02) : 243 - 253
  • [38] ROBERTS WM, 1989, CANCER RES, V49, P5407
  • [39] ATM: A mediator of multiple responses to genotoxic stress
    Rotman, G
    Shiloh, Y
    [J]. ONCOGENE, 1999, 18 (45) : 6135 - 6144
  • [40] Multicolor spectral karyotyping of human chromosomes
    Schrock, E
    duManoir, S
    Veldman, T
    Schoell, B
    Wienberg, J
    FergusonSmith, MA
    Ning, Y
    Ledbetter, DH
    BarAm, I
    Soenksen, D
    Garini, Y
    Ried, T
    [J]. SCIENCE, 1996, 273 (5274) : 494 - 497